Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development
11 oct. 2023 08h50 HE
|
Revive Therapeutics Ltd.
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...